Weekly News Letters

Weekly News Letters

Ethical Considerations in Preclinical Trials

Ethical Consideration in Preclinical Trials Preclinical trials are essential for evaluating the safety and effectiveness of new drugs and treatments before they are tested on humans. While these studies play a vital role in advancing medical research, they also involve ethical challenges that must be carefully navigated to ensure responsible and humane practices. Upholding Animal […]

Ethical Considerations in Preclinical Trials Read More »

Preclinical Research: The Foundation of Successful Drug Development

Preclinical Research: The Foundation of Successful Drug Development Preclinical research is the cornerstone of drug development, providing essential insights before a drug reaches human trials. It is the stage where safety, efficacy, and the biological behavior of drug candidates are rigorously tested, laying the groundwork for success in later phases. Contract Research Organizations (CROs) play

Preclinical Research: The Foundation of Successful Drug Development Read More »

Chronic Inflammation

Animal Model Development for Chronic Inflammation

Animal Model Development for Chronic Inflammation Chronic inflammation (CI), characterized by unresolved inflammation persisting for prolonged periods, can exacerbate tissue damage in various organs. Understanding the cellular and intracellular pathways involved in CI is crucial for developing effective treatments. Animal models play a significant role in studying CI mechanisms and in developing new therapies for

Animal Model Development for Chronic Inflammation Read More »

clinical trials diversity and Inclusion

Clinical Trials Diversity and Inclusion

Clinical Trials Diversity and Inclusion •   Why Diversity and Inclusion in Clinical Trials Matter Clinical trials are the cornerstone of medical advancements, driving innovation and improving patient care. However, historically, these trials have often lacked diversity, with underrepresentation of certain demographics such as racial and ethnic minorities, women, the elderly, and those with disabilities. Based

Clinical Trials Diversity and Inclusion Read More »

Scroll to Top

Dr. Fatima Tariq,

Business Development Officer

Dr. Fatima Tariq, Pharm.D is a pharmacy professional with experience across the retail, hospital, and pharmaceutical sectors. She earned her Doctor of Pharmacy degree from Akhtar Saeed College of Pharmaceutical Sciences, affiliated with the University of the Punjab.

She began her career as an IPD Pharmacist at Hameed Latif Hospital and later transitioned into business development within the pharmaceutical industry. Currently, she serves as a Business Development Officer at Trial 360.

Her expertise includes business development strategies, client relationship management, market research, competitive analysis, stakeholder engagement, and identifying growth opportunities. Combining pharmaceutical knowledge with commercial insight, she is committed to fostering strategic partnerships and driving sustainable business growth within the healthcare and clinical research landscape.